Business Wire: July 24, 2017 – JERUSALEM, Israel – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of Vagifem® 1 (estradiol vaginal inserts), 10 mcg in the United States. Estradiol vaginal inserts are an estrogen indicated for the treatment…
